A 17beta-Hydroxy-17-methyl-5alpha-androstano(3,2-c)pyrazole DMF (Drug Master File) is a document detailing the whole manufacturing process of 17beta-Hydroxy-17-methyl-5alpha-androstano(3,2-c)pyrazole active pharmaceutical ingredient (API) in detail. Different forms of 17beta-Hydroxy-17-methyl-5alpha-androstano(3,2-c)pyrazole DMFs exist exist since differing nations have different regulations, such as 17beta-Hydroxy-17-methyl-5alpha-androstano(3,2-c)pyrazole USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A 17beta-Hydroxy-17-methyl-5alpha-androstano(3,2-c)pyrazole DMF submitted to regulatory agencies in the US is known as a USDMF. 17beta-Hydroxy-17-methyl-5alpha-androstano(3,2-c)pyrazole USDMF includes data on 17beta-Hydroxy-17-methyl-5alpha-androstano(3,2-c)pyrazole's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The 17beta-Hydroxy-17-methyl-5alpha-androstano(3,2-c)pyrazole USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of 17beta-Hydroxy-17-methyl-5alpha-androstano(3,2-c)pyrazole suppliers with USDMF on PharmaCompass.